Every 10-Q that Novanta Inc (NOVT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow NOVT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NOVT filings page.
Novanta Inc. reported Q2 2026 revenue of 265,807 (in thousands of U.S. dollars), up from 241,049 (in thousands) a year earlier, with net income of 12,541 (in thousands) versus 4,497 (in thousands). Diluted earnings per share were $0.30, compared with $0.12 in Q2 2025.
For the first six months of 2026, revenue reached 523,514 (in thousands) and net income was 33,640 (in thousands). Operating cash flow increased to 116,540 (in thousands), lifting cash and cash equivalents to 718,650. The company strengthened its capital base through a private placement of 2,142,857 common shares for net proceeds of about $287.6 million and continues to use tangible equity units and term loans under its credit facilities. Novanta is executing multi‑year restructuring programs, with cumulative 2025 program costs of 18.7 million (in thousands) to date and an expected total of approximately $30.0 million, and has been repurchasing shares under its 2020 and 2025 repurchase plans.
Novanta Inc. reported solid Q1 2026 revenue growth while earnings were roughly flat. Revenue rose to $257.7M from $233.4M, driven by both Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies generated $131.2M and Medical Solutions $126.5M of revenue.
Net income was stable at $21.1M versus $21.2M a year earlier, with diluted EPS slipping to $0.51 from $0.59 as the share count increased. Operating income declined to $27.5M from $32.4M as selling, general and administrative expenses and restructuring and acquisition costs increased.
Operating cash flow strengthened to $51.6M from $31.7M, supporting a cash balance of $388.8M and total debt of $241.4M. The company continued buybacks, repurchasing 159 thousand shares for $18.6M, and ended the quarter with 35.6M common shares outstanding.
Novanta Inc. reported Q3 2025 results. Revenue was $247.8 million, slightly above last year, while operating income fell to $21.8 million and net income was $10.7 million (diluted EPS $0.30). For the first nine months, revenue reached $722.3 million with net income of $36.4 million. Higher selling, general and administrative costs and restructuring, acquisition, and related costs weighed on margins.
The balance sheet expanded to $1.51 billion in assets, driven by the April 8 acquisition of Keonn Technologies, which added $33.2 million of identifiable intangibles and $43.2 million of goodwill and contributed $19.9 million of revenue and $1.0 million of profit before income taxes year-to-date. Cash from operations was $55.3 million; cash ended at $89.2 million. Debt totaled $451.3 million following a new approximately $1.0 billion credit agreement maturing in 2030, with $306.6 million drawn on the revolver and $150.4 million in term loans. The company repurchased 179 thousand shares for $21.1 million and authorized a new $200.0 million repurchase plan. Shares outstanding were 35,775,123 as of October 27, 2025.